BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31362721)

  • 21. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Yao H; Cottin Y; Chagué F; Maza M; Bichat F; Zeller M; Putot A
    Am Heart J; 2023 Dec; 266():86-97. PubMed ID: 37703947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.
    Feinstein MJ; Nance RM; Drozd DR; Ning H; Delaney JA; Heckbert SR; Budoff MJ; Mathews WC; Kitahata MM; Saag MS; Eron JJ; Moore RD; Achenbach CJ; Lloyd-Jones DM; Crane HM
    JAMA Cardiol; 2017 Feb; 2(2):155-162. PubMed ID: 28002550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type.
    Hoang TH; Lazarev PV; Maiskov VV; Merai IA; Kobalava ZD
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):463-472. PubMed ID: 33836638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination of patients with type 2 myocardial infarction.
    Neumann JT; Sörensen NA; Rübsamen N; Ojeda F; Renné T; Qaderi V; Teltrop E; Kramer S; Quantius L; Zeller T; Karakas M; Blankenberg S; Westermann D
    Eur Heart J; 2017 Dec; 38(47):3514-3520. PubMed ID: 29020401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
    Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
    Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
    Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
    Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Ishak A; Nasir YM; Chia JE; Naz S; Jaiswal A
    J Investig Med; 2023 Mar; 71(3):223-234. PubMed ID: 36705027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.
    Putot A; Jeanmichel M; Chagué F; Avondo A; Ray P; Manckoundia P; Zeller M; Cottin Y
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.
    Lang R; Humes E; Hogan B; Lee J; D'Agostino R; Massaro J; Kim A; Meigs JB; Borowsky L; He W; Lyass A; Cheng D; Kim HN; Klein MB; Cachay ER; Bosch RJ; Gill MJ; Silverberg MJ; Thorne JE; McGinnis K; Horberg MA; Sterling TR; Triant VA; Althoff KN
    J Am Heart Assoc; 2022 Oct; 11(19):e026473. PubMed ID: 36129038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality.
    Meigher S; Thode HC; Peacock WF; Bock JL; Gruberg L; Singer AJ
    Acad Emerg Med; 2016 Nov; 23(11):1267-1273. PubMed ID: 27320126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial infarction during giant cell arteritis: A cohort study.
    Greigert H; Zeller M; Putot A; Steinmetz E; Terriat B; Maza M; Falvo N; Muller G; Arnould L; Creuzot-Garcher C; Ramon A; Martin L; Tarris G; Ponnelle T; Audia S; Bonnotte B; Cottin Y; Samson M
    Eur J Intern Med; 2021 Jul; 89():30-38. PubMed ID: 33610415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis.
    Putot A; Jeanmichel M; Chague F; Manckoundia P; Cottin Y; Zeller M
    Aging Dis; 2020 Feb; 11(1):108-117. PubMed ID: 32010485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.